Search

Your search keyword '"ML. Calabrò"' showing total 88 results

Search Constraints

Start Over You searched for: Author "ML. Calabrò" Remove constraint Author: "ML. Calabrò"
88 results on '"ML. Calabrò"'

Search Results

1. A novel HPLC method for the determination of mitoxantrone in pharmaceutical formulations

2. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy

3. Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling

4. Optimization of a LC method for the enantioseparation of a non-competitive glutamate receptor antagonist, by experimental design methodology

5. Stemness and hybrid epithelial-mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritonei.

6. Kaposi sarcoma and vertebral involvement in people with HIV: a case report and systematic literature review.

7. Drug Combination Studies of Isoquinolinone AM12 with Curcumin or Quercetin: A New Combination Strategy to Synergistically Inhibit 20S Proteasome.

8. Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series.

9. Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma.

10. Novel Perspectives in Pseudomyxoma Peritonei Treatment.

11. Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells.

12. Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.

13. Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic Sarcoma.

14. Circulating miRNA-375 as a potential novel biomarker for active Kaposi's sarcoma in AIDS patients.

15. Human Herpesvirus 8 and Lymphoproliferative Disorders.

16. A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.

17. Development of extraction method for characterization of free and bonded polyphenols in barley (Hordeum vulgare L.) grown in Czech Republic using liquid chromatography-tandem mass spectrometry.

18. Recurrent Kaposi sarcoma associated with Koebner phenomenon in two HIV-seronegative patients: Two case reports and a review of the literature.

19. Rapid isolation, reliable characterization, and water solubility improvement of polymethoxyflavones from cold-pressed mandarin essential oil.

20. Neck Kaposiform haemangioendothelioma in a Fischer's lovebird (Agapornis fischeri).

21. Predictors of immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: a case report.

22. Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.

23. Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

24. Crosstalk between the mesothelium and lymphomatous cells: insight into the mechanisms involved in the progression of body cavity lymphomas.

25. Structural and spectroscopic features of lutein/butanoyl-β-cyclodextrin nanoassemblies.

26. Evaluation of fast PCR reagents for rapid and sensitive detection of human herpesvirus 8.

27. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors.

28. Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment.

29. Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies.

30. Antineoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma.

31. Synthesis, chiral resolution and pharmacological evaluation of a 2,3-benzodiazepine-derived noncompetitive AMPA receptor antagonist.

32. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.

33. Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus.

34. In vitro and in vivo human herpesvirus 8 infection of placenta.

35. The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis.

36. Enantioseparation, absolute configuration determination, and anticonvulsant activity of (+/-)-1-(4-aminophenyl)-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-one.

37. Optimization of a LC method for the enantioseparation of a non-competitive glutamate receptor antagonist, by experimental design methodology.

38. Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women.

39. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated polyclonal body cavity effusions that mimic primary effusion lymphomas.

40. High human herpesvirus 8 seroprevalence in populations from Western Balkan countries.

41. Enantioselective recognition of 2,3-benzodiazepin-4-one derivatives with anticonvulsant activity on several polysaccharide chiral stationary phases.

42. The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin.

43. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.

44. Use of a BJAB-derived cell line for isolation of human herpesvirus 8.

45. The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays.

46. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin.

47. HHV-8 transmission via saliva to soothe blood-sucking arthropod bites.

48. Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites.

49. Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin.

50. Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice.

Catalog

Books, media, physical & digital resources